Back to News
Home/Global Finance & DevelopmentBy Robert Garcia William Martin

The Unspoken Price of African Health: Why Remittance Insurance is a Trojan Horse for Foreign Capital

The Unspoken Price of African Health: Why Remittance Insurance is a Trojan Horse for Foreign Capital

Remittance-based insurance promises to solve Africa's health financing gap, but who truly profits from this new wave of diaspora finance?

Key Takeaways

  • Remittance insurance risks benefiting foreign underwriters more than African health systems.
  • The model shifts focus from demanding national government accountability to private premium payments.
  • The real long-term asset being captured is granular health and spending data on African populations.
  • Future success hinges on mandating strong local ownership and transparent governance.

Frequently Asked Questions

What is the primary criticism of remittance-based insurance for Africa?

The main criticism is that it creates a lucrative, captive market for foreign insurance and FinTech companies, shifting the focus away from demanding better governance and public investment in national healthcare systems.

How much money is involved in African remittances?

Remittances to Africa now exceed $50 billion annually, representing a massive pool of private capital that financial institutions are eager to structure and manage.

What is the 'health financing gap' in Africa?

It refers to the significant shortfall between the funds required to provide essential, quality healthcare services to the population and the actual domestic and international public funds available.

Are there successful examples of localized health financing models?

While remittance insurance is new, successful localized models often involve community-based health insurance schemes or national health savings programs that maintain direct control over funds.